Immunodetection of the amyloid P component in Alzheimer's disease

Taihung Duong, E. C. Pommier, A. B. Scheibel

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Amyloid P component (AP), a plasma constituent normally not found in brain arenchyma, has been immunohistochemically determined in brains from patients with Alzheimer's disease (AD). Tissue came from 11 clinically diagnosed and neuropathologically verified AD patients and from 6 normal aged controls. Positive labeling for AP was observed in amyloidotic blood vessels, senile plaques (SP) and neurofibrillary tangles (NFT). The immunoreactivity was specific for these AD-associated lesions and clearly revealed their morphological appearance. Affected blood vessels appeared to be mainly of the arteriolar types and were labeled abluminally in short segments. SP constituents such as amyloid fibrils, anyloid core and degenerative axonal and dendritic processes were positive for AP antiserum; the morphology and distribution of immunoreactive SP corresponded to previous descriptions. Labeling of NFT revealed the morphology of paired helical and straight filaments. In all cerebral areas studied, tangle-bearing neurons were immunoreactive to AP antiserum, suggesting that AP is involved in early cellular development of NFT. Given the large molecular weight of AP (about 220,000), these results point to a potential impairment of the blood-brain barrier in AD. Since AP is always present in systemic amyloidosis, its detection in cerebral amyloidosis associated with AD may suggest mechanisms common to the two disorders.

Original languageEnglish (US)
Pages (from-to)429-437
Number of pages9
JournalActa Neuropathologica
Volume78
Issue number4
DOIs
StatePublished - Jul 1989
Externally publishedYes

Fingerprint

Serum Amyloid P-Component
Alzheimer Disease
Neurofibrillary Tangles
Amyloid Plaques
Blood Vessels
Immune Sera
Brain
Amyloidosis
Blood-Brain Barrier
Amyloid
Molecular Weight
Neurons

Keywords

  • Alzheimer's disease
  • Amyloid P component
  • Amyloidosis
  • Neurofibrils

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pathology and Forensic Medicine
  • Clinical Neurology

Cite this

Immunodetection of the amyloid P component in Alzheimer's disease. / Duong, Taihung; Pommier, E. C.; Scheibel, A. B.

In: Acta Neuropathologica, Vol. 78, No. 4, 07.1989, p. 429-437.

Research output: Contribution to journalArticle

Duong, Taihung ; Pommier, E. C. ; Scheibel, A. B. / Immunodetection of the amyloid P component in Alzheimer's disease. In: Acta Neuropathologica. 1989 ; Vol. 78, No. 4. pp. 429-437.
@article{fc7bb9d3dd714b95839d692817f8347a,
title = "Immunodetection of the amyloid P component in Alzheimer's disease",
abstract = "Amyloid P component (AP), a plasma constituent normally not found in brain arenchyma, has been immunohistochemically determined in brains from patients with Alzheimer's disease (AD). Tissue came from 11 clinically diagnosed and neuropathologically verified AD patients and from 6 normal aged controls. Positive labeling for AP was observed in amyloidotic blood vessels, senile plaques (SP) and neurofibrillary tangles (NFT). The immunoreactivity was specific for these AD-associated lesions and clearly revealed their morphological appearance. Affected blood vessels appeared to be mainly of the arteriolar types and were labeled abluminally in short segments. SP constituents such as amyloid fibrils, anyloid core and degenerative axonal and dendritic processes were positive for AP antiserum; the morphology and distribution of immunoreactive SP corresponded to previous descriptions. Labeling of NFT revealed the morphology of paired helical and straight filaments. In all cerebral areas studied, tangle-bearing neurons were immunoreactive to AP antiserum, suggesting that AP is involved in early cellular development of NFT. Given the large molecular weight of AP (about 220,000), these results point to a potential impairment of the blood-brain barrier in AD. Since AP is always present in systemic amyloidosis, its detection in cerebral amyloidosis associated with AD may suggest mechanisms common to the two disorders.",
keywords = "Alzheimer's disease, Amyloid P component, Amyloidosis, Neurofibrils",
author = "Taihung Duong and Pommier, {E. C.} and Scheibel, {A. B.}",
year = "1989",
month = "7",
doi = "10.1007/BF00688180",
language = "English (US)",
volume = "78",
pages = "429--437",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Immunodetection of the amyloid P component in Alzheimer's disease

AU - Duong, Taihung

AU - Pommier, E. C.

AU - Scheibel, A. B.

PY - 1989/7

Y1 - 1989/7

N2 - Amyloid P component (AP), a plasma constituent normally not found in brain arenchyma, has been immunohistochemically determined in brains from patients with Alzheimer's disease (AD). Tissue came from 11 clinically diagnosed and neuropathologically verified AD patients and from 6 normal aged controls. Positive labeling for AP was observed in amyloidotic blood vessels, senile plaques (SP) and neurofibrillary tangles (NFT). The immunoreactivity was specific for these AD-associated lesions and clearly revealed their morphological appearance. Affected blood vessels appeared to be mainly of the arteriolar types and were labeled abluminally in short segments. SP constituents such as amyloid fibrils, anyloid core and degenerative axonal and dendritic processes were positive for AP antiserum; the morphology and distribution of immunoreactive SP corresponded to previous descriptions. Labeling of NFT revealed the morphology of paired helical and straight filaments. In all cerebral areas studied, tangle-bearing neurons were immunoreactive to AP antiserum, suggesting that AP is involved in early cellular development of NFT. Given the large molecular weight of AP (about 220,000), these results point to a potential impairment of the blood-brain barrier in AD. Since AP is always present in systemic amyloidosis, its detection in cerebral amyloidosis associated with AD may suggest mechanisms common to the two disorders.

AB - Amyloid P component (AP), a plasma constituent normally not found in brain arenchyma, has been immunohistochemically determined in brains from patients with Alzheimer's disease (AD). Tissue came from 11 clinically diagnosed and neuropathologically verified AD patients and from 6 normal aged controls. Positive labeling for AP was observed in amyloidotic blood vessels, senile plaques (SP) and neurofibrillary tangles (NFT). The immunoreactivity was specific for these AD-associated lesions and clearly revealed their morphological appearance. Affected blood vessels appeared to be mainly of the arteriolar types and were labeled abluminally in short segments. SP constituents such as amyloid fibrils, anyloid core and degenerative axonal and dendritic processes were positive for AP antiserum; the morphology and distribution of immunoreactive SP corresponded to previous descriptions. Labeling of NFT revealed the morphology of paired helical and straight filaments. In all cerebral areas studied, tangle-bearing neurons were immunoreactive to AP antiserum, suggesting that AP is involved in early cellular development of NFT. Given the large molecular weight of AP (about 220,000), these results point to a potential impairment of the blood-brain barrier in AD. Since AP is always present in systemic amyloidosis, its detection in cerebral amyloidosis associated with AD may suggest mechanisms common to the two disorders.

KW - Alzheimer's disease

KW - Amyloid P component

KW - Amyloidosis

KW - Neurofibrils

UR - http://www.scopus.com/inward/record.url?scp=0024340461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024340461&partnerID=8YFLogxK

U2 - 10.1007/BF00688180

DO - 10.1007/BF00688180

M3 - Article

VL - 78

SP - 429

EP - 437

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 4

ER -